The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Multikinase and highly selective kinase inhibitors in the neoadjuvant treatment of patients with thyroid cancer”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2026 |
Rosa Bock, Sam Arman, Gracia Lana Ardila Pardo, Anna Loroch, Ashley Hay, Brendan Conn, Alan Christie, David Noble, Reena Dwivedi, Mark Strachan, Lucy Wall, Iain J. Nixon. Neoadjuvant tyrosine kinase inhibitor therapy for locally advanced, well-differentiated thyroid cancer, The Surgeon. 2026; https://doi.org/10.1016/j.surge.2026.05.001 |
|
2 |
2026 |
Jaewang Lee, Jong-Lyel Roh. Ferroptosis in Differentiated Thyroid Cancer: Redox–Iodine Metabolism, Dedifferentiation, and Therapeutic Sensitization Beyond Anaplastic Disease, Cells. 2026; 15: 630. https://doi.org/10.3390/cells15070630 |
|
3 |
2026 |
Omer Faruk Dilbaz, Ozben Yalcin. 2026; https://doi.org/10.5772/intechopen.1014764 |
|
4 |
2026 |
Antonio Matrone, Marianna Scordo, Elisa Minaldi, Liborio Torregrossa, Gabriele Materazzi, Rossella Elisei. Fatal tracheal perforation following Dabrafenib-Trametinib therapy in BRAF V600E-mutant mixed anaplastic thyroid cancer, JCEM Case Reports. 2026; 4: luag027. https://doi.org/10.1210/jcemcr/luag027 |
|
5 |
2025 |
Gülşah Altun, Özlem Yönem. Cytotoxic Effects of Sorafenib, Lapatinib, and Bevacizumab, Alone and in Combination, on Medullary Thyroid Carcinoma Cells, Current Oncology. 2025; 32: 607. https://doi.org/10.3390/curroncol32110607 |
|
6 |
2025 |
Ekaterina M. Zhidkova, Ekaterina D. Savina, Ekaterina A. Yurchenko, Ekaterina A. Lesovaya. Marine-Derived Steroids for Cancer Treatment: Search for Potential Selective Glucocorticoid Receptor Agonists/Modulators (SEGRAMs), Marine Drugs. 2025; 23: 399. https://doi.org/10.3390/md23100399 |